PMN Archived Articles
ProMIS Neurosciences (NASDAQ:PMN): Pioneering Antibody Therapeutics Targeting Toxic Misfolded Proteins in Neurodegenerative Diseases
Published on November 28, 2024
ProMIS Neurosciences Inc. (NASDAQ:PMN): A Promising Alzheimer's Antibody and a Diversified Pipeline
Published on September 24, 2024